Eric C. Strain

Eric C. Strain, MD, is a Professor in the School of Medicine at Johns Hopkins University, specializing in Mental Health through his primary appointment at Johns Hopkins Bayview Medical Center in Baltimore, Maryland. His clinical and research activities focus on advancing understanding and treatment of substance use disorders within the institution's renowned medical framework.

His educational foundation includes:

• MD from Ohio State University (1984)

Dr. Strain's research program centers on opioid pharmacology and addiction treatment, with deep expertise in buprenorphine and methadone therapies, opioid withdrawal mechanisms, and placebo effects in clinical trials. His work bridges laboratory science with population health, examining how social determinants influence pain management and substance use outcomes. Current investigations extend into policy implications of drug legalization, ethical dimensions of treatment records, and health disparities affecting vulnerable populations.

Analysis of his 2025 publications reveals a strategic pivot toward emerging public health challenges: psychedelic therapy evidence synthesis, fentanyl withdrawal severity in the illicit drug market, structural inequities in pain treatment, and patient-centered approaches to reducing stigma in substance use care. These works demonstrate methodological diversity across quasi-experimental designs, scoping reviews, and qualitative patient interviews.

No major scientific awards are documented in the provided materials.

While specific grant funding details remain undisclosed, his 226 total research outputs indicate sustained extramural support. The absence of listed advisees suggests primary focus on independent research leadership rather than formal graduate student supervision, though his collaborative publications imply mentorship within multi-investigator teams.

Dr. Strain operates within Johns Hopkins Bayview Medical Center's integrated research ecosystem, leveraging institutional strengths in clinical trial infrastructure and population health sciences to address the opioid crisis through both pharmacological and policy-oriented solutions.